17.27USDMkt Cap: 2.30B $P/E: 7.571d ago
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYN…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap2.30B $
Enterprise Value1.77B $
Revenue (TTM)311.51M $
Gross Profit250.39M $
Net Income (TTM)287.20M $
Revenue/Share2.368 USD
Last Price17.27 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees128
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA05156V1022
Valuation
P/E (Trailing)7.57
P/E (Forward)16.19
PEG—
EV/EBITDA9.86
EV/Revenue5.69
P/S7.38
P/B3.73
EPS (TTM)2.44
EPS (Forward)1.07
52W Range
16.6056% of range17.79
52W High17.79 USD
52W Low16.60 USD
Profitability
Gross Margin88.46%
Oper. Margin55.68%
EBITDA Margin57.73%
Profit Margin101.47%
ROE49.40%
ROA38.21%
Growth
Revenue Growth18.90%
Earnings Growth75.50%
Cash Flow & Leverage
Operating CF135.66M $
CapEx (TTM)252.00K $
FCF Margin47.45%
FCF Yield6.43%
Net Debt-378.89M $
Net Debt/EBITDA-2.11
Balance Sheet
Debt/Equity0.13
Current Ratio5.42
Quick Ratio4.86
Book Value/Sh4.626 USD
Cash/Share3.330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.17 USD
Upside (mean)+5.2%
Target Range16.00 USD – 21.00 USD
$16.00+5.2% to mean$21.00
# Analysts6
Ownership
Shares Out.133.05M
Float128.82M
Insiders7.28%
Institutions60.39%
Short Interest
Short Ratio7.0d
Short % Float7.91%
Short % Out.7.17%
Shares Short9.53M
Short (prev mo.)9.59M
Technical
SMA 5015.89 (+8.7%)
SMA 20015.38 (+12.3%)
Beta1.40
S&P 52W Chg21.00%
Avg Vol (30d)2.60M
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—